Osiris Therapeutics (OSIR) Posts Q2 EPS of $0.05, Tops by 4c

August 6, 2010 7:05 AM EDT Send to a Friend

Osiris Therapeutics, Inc. (Nasdaq: OSIR) reports Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Osiris Therapeutics (OSIR) Posts Q2 EPS of $0.05, Tops by 4c

Member Login

Free News Feed